Innoveda Biological Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-07-2024
- Paid Up Capital ₹ 0.43 M
as on 11-07-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 288.09%
(FY 2020)
- Profit -100.80%
(FY 2020)
- Ebitda -120.94%
(FY 2020)
- Net Worth 127.04%
(FY 2020)
- Total Assets 1099.06%
(FY 2020)
About Innoveda Biological Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.43 M, as per Ministry of Corporate Affairs (MCA) records.
Anirudha Mohite and Ram Kumar serve as directors at the Company.
- CIN/LLPIN
U24239DL2008PTC178821
- Company No.
178821
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Innoveda Biological Solutions Private Limited offer?
Innoveda Biological Solutions Private Limited offers a wide range of products and services, including Diabetic Medicines, Ayurvedic Medicines.
Who are the key members and board of directors at Innoveda Biological Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Kumar  | Additional Director | 23-Feb-2021 | Current |
| Anirudha Mohite | Additional Director | 27-Aug-2021 | Current |
Financial Performance of Innoveda Biological Solutions.
Innoveda Biological Solutions Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 288.09% increase. The company also saw a substantial fall in profitability, with a 100.8% decrease in profit. The company's net worth Soared by an impressive increase of 127.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innoveda Biological Solutions?
In 2019, Innoveda Biological Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innoveda Biological Solutions?
Unlock and access historical data on people associated with Innoveda Biological Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innoveda Biological Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoveda Biological Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
